BAX and neoplasm: Interestingly, overall bulk tumor response to 17-AAG is independent of BAX status, both in vitro and in vivo, which is likely due to the predominance of a cytostatic antiproliferative response combined with the induction of an alternative cell death mechanism when apoptosis is blocked.